Ignite Creation Date:
2024-05-06 @ 3:18 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02255084
Status:
COMPLETED
Last Update Posted:
2016-10-26
First Post:
2014-09-29
Brief Title:
Vaginal Self-sampling and Human Papillomavirus Testing in Unscreened Women
Sponsor:
University Hospital Tours
Organization:
University Hospital Tours
Study Overview
Official Title:
Attitude of Unscreened Women Face to Different Strategies to Participate in Cervical Cancer Screening by Vaginal Self-sampling Home-mailed or Invitation to Remove to Their General Practitioner
Status:
COMPLETED
Status Verified Date:
2016-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
APACHE-3
Brief Summary:
Despite the existence of an effective screening test pap smear cervical cancer is every year in France the cause of more than 3000 new cases and 1100 deaths But in France 4 in 10 women are not screened or not often enough nearly 7 millions women It is therefore necessary to develop new strategies to reach these women The etiological factor of this cancer is persistent infection with High-Risk Human PapillomaVirus oncogene HR-HPV Thereby HPV-based tests could be alternative screening tests Vaginal self-sampling with HR-HPV test is simpler and less intrusive than the pap smear It has been shown that vaginal self-sampling with HPV test is a powerful means to increase the participation rate in cervical cancer screening
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None